Ocumension Therapeutics 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jan 16, 2024
Insider Transaction Report
Form 4
Ocumension Therapeutics
Director
Transactions
- Sale
common stock
[F1]2024-01-11$19.45/sh−1,910,500$37,159,225→ 100,221 total
Footnotes (1)
- [F1]T+2 settlement on Jan 16
Signature
/s/ Ye Liu|2024-01-16